Invention Grant
- Patent Title: Substituted pyridines as selective cyclooxygenase-2 inhibitors
-
Application No.: US181887Application Date: 1998-10-29
-
Publication No.: US6001843APublication Date: 1999-12-14
- Inventor: Daniel Dube , Rejean Fortin , Richard Friesen , Zhaoyin Wang , Jacques Yves Gauthier
- Applicant: Daniel Dube , Rejean Fortin , Richard Friesen , Zhaoyin Wang , Jacques Yves Gauthier
- Applicant Address: NJ Rahway
- Assignee: Merck & Co., Inc.
- Current Assignee: Merck & Co., Inc.
- Current Assignee Address: NJ Rahway
- Main IPC: A61K31/44
- IPC: A61K31/44 ; A61K31/444 ; A61K31/655 ; C07D213/04 ; C07D213/22 ; C07D213/26 ; C07D213/34 ; C07D213/36 ; C07D213/44 ; C07D213/54 ; C07D213/61 ; C07D213/65 ; C07D213/75 ; C07D213/80 ; C07D213/85 ; C07D213/89 ; A61K31/535 ; C07D211/70 ; C07D211/72 ; C07D211/78
Abstract:
The invention encompasses the novel compound of Formula I as well as a method of treating COX-2 mediated diseases comprising administration to a patient in need of such treatment of a non-toxic therapeutically effective amount of a compound of Formula I. The invention also encompasses certain pharmaceutical compositions for treatment of COX-2 mediated diseases comprising compounds of Formula I.
Public/Granted literature
- US5433946A Synthesis and utilization of therapeutic agents for the treatment of lysosomal storage diseases Public/Granted day:1995-07-18
Information query
